Aveo Capital Partners, LLC Bristol Myers Squibb CO Transaction History

Aveo Capital Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $2,299 - $2,608	-35 Reduced 1.13%	3,052 $211,000
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $23,899 - $28,300	-349 Reduced 10.16%	3,087 $222,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $42 - $25,357	-330 Reduced 8.76%	3,436 $244,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $1,525 - $1,679	-21 Reduced 0.55%	3,766 $290,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $122 - $147	2 Added 0.05%	3,787 $277,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $25,581 - $29,822	-477 Reduced 11.19%	3,785 $236,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $42,898 - $50,249	-725 Reduced 14.54%	4,262 $252,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $47,423 - $51,643	766 Added 18.15%	4,987 $333,000
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $250,474 - $281,709	4,221 New	4,221 $266,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Aveo Capital Partners, LLC with notifications on news.